2001  2002  2003  2004  2005  2006  2007  2008

NEWS of 2008

07.2008 New chip for screening 6 genes connected with Hereditary Breast and Ovarian Cancer

This novel approach is an ideal pre-screening device for analysing 88 positions in the BRCA1, BRCA2, CHEK2, RAD51, NBN and CASP8.

06.2008 Asper Biotech's new test for Wilson Disease screening

The genetic test has been developed for screening 104 mutations in the ATP7B gene.

Development and chip validation experiments have been performed in collaboration with the University of Brno in the Czech Republic and was reviewed in an article published in Clinical Genetics earlier this year.

05.2008 Asper Ophthalmics has updated the BBS chip.

70 new positions have been added to the BBS chip. Currently the test can be used for screening 307 mutations in 14 genes: BBS1, BBS2, BBS3, BBS4, BBS5, BBS6, BBS7, BBS8, BBS9, BBS10, BBS12, PHF6, ALMS1 and GNAS1.

04.2008 New publication co-authored by Asper scientist was published:

Genotyping microarray as a novel approach for the detection of ATP7B gene mutations in patients with Wilson disease
Gojova L., Jansova E., Külm M., Pouchla S., Kozak L.
Clinical Genetics 2008: 73: 441–452

The chip has been updated by adding 8 new mutations to the test. The current test version covers 77 mutations from 22 different genes related to Cystic Fibrosis, Tay Sachs, Bloom -, Canavan -, Niemann-Pick A syndrome, Familian dysautonomia, Torsion dystonia, Mucolipidosis IV, Fanconi Anemia, Factor XI deficiency, Glycogen storage disease, Marple Syrup Urine disease, Nonsyndromic sensorineural hearing loss, Familial mediterranean fever, Alpha 1-anti-trypsin Deficiency, Nemaline Myopathy, Usher Syndrome Type 1F, Familial hyperinsulinemia, Familial Hypercholesterolemia, Gaucher disease and Lipoamide Dehydrogenase Deficiency.

04.2008 Asper Ophthalmics will be represented at the 15th Retina International World Congress "Research into practice" with its exhibition stand. 

The congress will be held in Finlandia Hall, Helsinki, Finland on 4th-5th July, 2008. Asper welcomes all existing partners and everyone interested in collaboration with Asper to attend the congress and meet in its booth.

03.2008 Leber congenital amaurosis chip updated.

44 new mutations and 1 new gene (LCA5) can be analyzed by  LCA  chip. Currently the test can be used for the screening of 495 mutations in 12 genes: AIPL1, CRB1, CRX, GUCY2D, LRAT, MERTK, CEP290, RDH12, RPGRIP1, RPE65, LCA5 and TULP1.

02.2008 Asper Ophthalmics will be represented at the ARVO 2008 - Eyes on Innovation - in Fort Lauderdale, Florida, USA, on April 27-April 30.
 
As last three years, Asper will be represented at the meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2008. The meeting will be held in Broward County Convention Center, Fort Lauderdale, Florida, USA on April 27-April 30. Asper welcomes all existing partners and everyone interested in collaboration with Asper to attend the conference and meet in its booth #715.

02.2008 Asper Biotech invites all interested to its booth #444 at the 40th European Human Genetics Conference - ESHG 2008 in Barcelona, Spain, 31 May - 3 June.
 
Asper will be represented at the 40th European Human Genetics Conference - ESHG 2008. The conference will be held in Center Convencions Internacional Barcelona - CCIB, Barcelona, Spain on May 31-June 3. Asper welcomes all existing partners and everyone interested in collaboration with Asper to attend the conference and meet in its booth #444.